UniProt ID | WDR1_HUMAN | |
---|---|---|
UniProt AC | O75083 | |
Protein Name | WD repeat-containing protein 1 | |
Gene Name | WDR1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 606 | |
Subcellular Localization | Cytoplasm, cytoskeleton . Cell projection, podosome . Cell junction . | |
Protein Description | Induces disassembly of actin filaments in conjunction with ADF/cofilin family proteins. [PubMed: 15629458 Enhances cofilin-mediated actin severing (By similarity Involved in cytokinesis. Involved in chemotactic cell migration by restricting lamellipodial membrane protrusions] | |
Protein Sequence | MPYEIKKVFASLPQVERGVSKIIGGDPKGNNFLYTNGKCVILRNIDNPALADIYTEHAHQVVVAKYAPSGFYIASGDVSGKLRIWDTTQKEHLLKYEYQPFAGKIKDIAWTEDSKRIAVVGEGREKFGAVFLWDSGSSVGEITGHNKVINSVDIKQSRPYRLATGSDDNCAAFFEGPPFKFKFTIGDHSRFVNCVRFSPDGNRFATASADGQIYIYDGKTGEKVCALGGSKAHDGGIYAISWSPDSTHLLSASGDKTSKIWDVSVNSVVSTFPMGSTVLDQQLGCLWQKDHLLSVSLSGYINYLDRNNPSKPLHVIKGHSKSIQCLTVHKNGGKSYIYSGSHDGHINYWDSETGENDSFAGKGHTNQVSRMTVDESGQLISCSMDDTVRYTSLMLRDYSGQGVVKLDVQPKCVAVGPGGYAVVVCIGQIVLLKDQRKCFSIDNPGYEPEVVAVHPGGDTVAIGGVDGNVRLYSILGTTLKDEGKLLEAKGPVTDVAYSHDGAFLAVCDASKVVTVFSVADGYSENNVFYGHHAKIVCLAWSPDNEHFASGGMDMMVYVWTLSDPETRVKIQDAHRLHHVSSLAWLDEHTLVTTSHDASVKEWTITY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MPYEIKKVFA -----CCHHHHHHHH | 29.05 | - | |
7 | Ubiquitination | -MPYEIKKVFASLPQ -CCHHHHHHHHCCHH | 48.52 | 21890473 | |
7 (in isoform 1) | Ubiquitination | - | 48.52 | 21890473 | |
7 (in isoform 3) | Ubiquitination | - | 48.52 | 21890473 | |
11 | Phosphorylation | EIKKVFASLPQVERG HHHHHHHCCHHHHHC | 29.17 | 28857561 | |
17 | Methylation | ASLPQVERGVSKIIG HCCHHHHHCCEEECC | 52.54 | 115919905 | |
20 | Phosphorylation | PQVERGVSKIIGGDP HHHHHCCEEECCCCC | 22.44 | 20068231 | |
20 (in isoform 1) | Phosphorylation | - | 22.44 | - | |
21 | Ubiquitination | QVERGVSKIIGGDPK HHHHCCEEECCCCCC | 35.62 | 21890473 | |
21 (in isoform 1) | Ubiquitination | - | 35.62 | 21890473 | |
21 (in isoform 3) | Ubiquitination | - | 35.62 | 21890473 | |
28 | Acetylation | KIIGGDPKGNNFLYT EECCCCCCCCCEEEE | 78.12 | 19608861 | |
28 | Ubiquitination | KIIGGDPKGNNFLYT EECCCCCCCCCEEEE | 78.12 | 21890473 | |
28 (in isoform 1) | Acetylation | - | 78.12 | - | |
28 (in isoform 1) | Ubiquitination | - | 78.12 | 21890473 | |
28 (in isoform 3) | Ubiquitination | - | 78.12 | 21890473 | |
34 | Phosphorylation | PKGNNFLYTNGKCVI CCCCCEEEECCEEEE | 8.27 | 29496907 | |
38 | Acetylation | NFLYTNGKCVILRNI CEEEECCEEEEEECC | 27.65 | 23749302 | |
38 | Ubiquitination | NFLYTNGKCVILRNI CEEEECCEEEEEECC | 27.65 | 21890473 | |
38 (in isoform 1) | Ubiquitination | - | 27.65 | 21890473 | |
38 (in isoform 3) | Ubiquitination | - | 27.65 | 21890473 | |
54 | Phosphorylation | NPALADIYTEHAHQV CHHHHHHHCCCCCEE | 13.46 | - | |
55 | Phosphorylation | PALADIYTEHAHQVV HHHHHHHCCCCCEEE | 22.94 | - | |
65 | Ubiquitination | AHQVVVAKYAPSGFY CCEEEEEEECCCCEE | 30.27 | - | |
65 | Acetylation | AHQVVVAKYAPSGFY CCEEEEEEECCCCEE | 30.27 | 26051181 | |
66 | Phosphorylation | HQVVVAKYAPSGFYI CEEEEEEECCCCEEE | 17.63 | 21406692 | |
69 | Phosphorylation | VVAKYAPSGFYIASG EEEEECCCCEEEEEC | 33.10 | 28152594 | |
72 | Phosphorylation | KYAPSGFYIASGDVS EECCCCEEEEECCCC | 10.09 | 20090780 | |
75 | Phosphorylation | PSGFYIASGDVSGKL CCCEEEEECCCCCCE | 26.43 | 28152594 | |
79 | Phosphorylation | YIASGDVSGKLRIWD EEEECCCCCCEEEEE | 34.64 | 21406692 | |
81 | Acetylation | ASGDVSGKLRIWDTT EECCCCCCEEEEECC | 27.38 | 19608861 | |
81 | Ubiquitination | ASGDVSGKLRIWDTT EECCCCCCEEEEECC | 27.38 | 19608861 | |
83 | Methylation | GDVSGKLRIWDTTQK CCCCCCEEEEECCCC | 31.29 | 115919913 | |
87 | Phosphorylation | GKLRIWDTTQKEHLL CCEEEEECCCCHHHH | 19.01 | 28857561 | |
88 | Phosphorylation | KLRIWDTTQKEHLLK CEEEEECCCCHHHHE | 34.86 | 28857561 | |
90 | Ubiquitination | RIWDTTQKEHLLKYE EEEECCCCHHHHEEE | 45.04 | 90473 | |
90 | Acetylation | RIWDTTQKEHLLKYE EEEECCCCHHHHEEE | 45.04 | 26822725 | |
90 (in isoform 1) | Ubiquitination | - | 45.04 | 21890473 | |
95 | Acetylation | TQKEHLLKYEYQPFA CCCHHHHEEECCCCC | 42.25 | 19608861 | |
95 | Ubiquitination | TQKEHLLKYEYQPFA CCCHHHHEEECCCCC | 42.25 | 19608861 | |
95 | Malonylation | TQKEHLLKYEYQPFA CCCHHHHEEECCCCC | 42.25 | 26320211 | |
95 (in isoform 1) | Ubiquitination | - | 42.25 | 21890473 | |
96 | Phosphorylation | QKEHLLKYEYQPFAG CCHHHHEEECCCCCC | 21.60 | 28102081 | |
98 | Phosphorylation | EHLLKYEYQPFAGKI HHHHEEECCCCCCCC | 20.56 | 25839225 | |
98 (in isoform 1) | Phosphorylation | - | 20.56 | - | |
104 | Acetylation | EYQPFAGKIKDIAWT ECCCCCCCCEEEEEC | 43.06 | 23749302 | |
104 | Ubiquitination | EYQPFAGKIKDIAWT ECCCCCCCCEEEEEC | 43.06 | - | |
106 | Ubiquitination | QPFAGKIKDIAWTED CCCCCCCEEEEECCC | 46.71 | - | |
114 | Phosphorylation | DIAWTEDSKRIAVVG EEEECCCCCEEEEEE | 20.01 | 28857561 | |
115 | Acetylation | IAWTEDSKRIAVVGE EEECCCCCEEEEEEC | 61.21 | 19608861 | |
115 | Ubiquitination | IAWTEDSKRIAVVGE EEECCCCCEEEEEEC | 61.21 | 21906983 | |
115 | 2-Hydroxyisobutyrylation | IAWTEDSKRIAVVGE EEECCCCCEEEEEEC | 61.21 | - | |
115 | Malonylation | IAWTEDSKRIAVVGE EEECCCCCEEEEEEC | 61.21 | 26320211 | |
115 (in isoform 1) | Ubiquitination | - | 61.21 | 21890473 | |
126 | Ubiquitination | VVGEGREKFGAVFLW EEECCHHHEEEEEEE | 47.97 | - | |
126 | Acetylation | VVGEGREKFGAVFLW EEECCHHHEEEEEEE | 47.97 | 25953088 | |
135 | Phosphorylation | GAVFLWDSGSSVGEI EEEEEEECCCCCEEE | 29.06 | 28857561 | |
137 | Phosphorylation | VFLWDSGSSVGEITG EEEEECCCCCEEECC | 26.29 | 28857561 | |
138 | Phosphorylation | FLWDSGSSVGEITGH EEEECCCCCEEECCC | 37.35 | 28060719 | |
143 | Phosphorylation | GSSVGEITGHNKVIN CCCCEEECCCCCEEC | 28.25 | 28857561 | |
151 | Phosphorylation | GHNKVINSVDIKQSR CCCCEECEEECCCCC | 15.28 | 24076635 | |
155 | Ubiquitination | VINSVDIKQSRPYRL EECEEECCCCCCEEE | 37.44 | - | |
155 | 2-Hydroxyisobutyrylation | VINSVDIKQSRPYRL EECEEECCCCCCEEE | 37.44 | - | |
155 | Acetylation | VINSVDIKQSRPYRL EECEEECCCCCCEEE | 37.44 | 25953088 | |
164 | Phosphorylation | SRPYRLATGSDDNCA CCCEEECCCCCCCCH | 41.64 | 20068231 | |
166 | Phosphorylation | PYRLATGSDDNCAAF CEEECCCCCCCCHHH | 37.12 | 25693802 | |
170 | Glutathionylation | ATGSDDNCAAFFEGP CCCCCCCCHHHCCCC | 3.58 | 22555962 | |
180 | Acetylation | FFEGPPFKFKFTIGD HCCCCCEEEEEEECC | 54.11 | 25953088 | |
180 | Ubiquitination | FFEGPPFKFKFTIGD HCCCCCEEEEEEECC | 54.11 | - | |
182 | Acetylation | EGPPFKFKFTIGDHS CCCCEEEEEEECCCC | 42.03 | 23749302 | |
182 | Ubiquitination | EGPPFKFKFTIGDHS CCCCEEEEEEECCCC | 42.03 | - | |
184 (in isoform 3) | Ubiquitination | - | 25.33 | 21890473 | |
188 (in isoform 3) | Ubiquitination | - | 18.70 | 21890473 | |
189 | Phosphorylation | KFTIGDHSRFVNCVR EEEECCCCCEEEEEE | 31.96 | 26437602 | |
198 | Phosphorylation | FVNCVRFSPDGNRFA EEEEEEECCCCCEEE | 16.12 | 27067055 | |
208 | Phosphorylation | GNRFATASADGQIYI CCEEEEEECCCEEEE | 23.65 | 28152594 | |
214 | Phosphorylation | ASADGQIYIYDGKTG EECCCEEEEECCCCC | 5.87 | 28152594 | |
216 | Phosphorylation | ADGQIYIYDGKTGEK CCCEEEEECCCCCCE | 11.15 | 28152594 | |
219 | Acetylation | QIYIYDGKTGEKVCA EEEEECCCCCCEEEE | 50.92 | 26051181 | |
219 | Ubiquitination | QIYIYDGKTGEKVCA EEEEECCCCCCEEEE | 50.92 | 21906983 | |
219 | Malonylation | QIYIYDGKTGEKVCA EEEEECCCCCCEEEE | 50.92 | 26320211 | |
219 (in isoform 1) | Ubiquitination | - | 50.92 | 21890473 | |
221 (in isoform 3) | Ubiquitination | - | 35.89 | 21890473 | |
223 | Acetylation | YDGKTGEKVCALGGS ECCCCCCEEEECCCC | 43.91 | 23749302 | |
223 | Ubiquitination | YDGKTGEKVCALGGS ECCCCCCEEEECCCC | 43.91 | 21906983 | |
223 (in isoform 1) | Ubiquitination | - | 43.91 | 21890473 | |
230 | Phosphorylation | KVCALGGSKAHDGGI EEEECCCCCCCCCCE | 25.52 | 26437602 | |
231 | Ubiquitination | VCALGGSKAHDGGIY EEECCCCCCCCCCEE | 53.68 | - | |
231 | Malonylation | VCALGGSKAHDGGIY EEECCCCCCCCCCEE | 53.68 | 26320211 | |
231 | Acetylation | VCALGGSKAHDGGIY EEECCCCCCCCCCEE | 53.68 | 26051181 | |
238 | Phosphorylation | KAHDGGIYAISWSPD CCCCCCEEEEEECCC | 10.93 | 19605366 | |
241 | Phosphorylation | DGGIYAISWSPDSTH CCCEEEEEECCCCCC | 17.21 | 28796482 | |
243 | Phosphorylation | GIYAISWSPDSTHLL CEEEEEECCCCCCEE | 16.43 | 28985074 | |
246 | Phosphorylation | AISWSPDSTHLLSAS EEEECCCCCCEEECC | 22.55 | 28857561 | |
247 | Phosphorylation | ISWSPDSTHLLSASG EEECCCCCCEEECCC | 24.75 | 28857561 | |
256 | Acetylation | LLSASGDKTSKIWDV EEECCCCCCCCEEEE | 59.22 | 23954790 | |
256 | Ubiquitination | LLSASGDKTSKIWDV EEECCCCCCCCEEEE | 59.22 | 21906983 | |
256 | 2-Hydroxyisobutyrylation | LLSASGDKTSKIWDV EEECCCCCCCCEEEE | 59.22 | - | |
256 | Malonylation | LLSASGDKTSKIWDV EEECCCCCCCCEEEE | 59.22 | 26320211 | |
256 (in isoform 1) | Ubiquitination | - | 59.22 | 21890473 | |
300 | Phosphorylation | LSVSLSGYINYLDRN EEEEHHHHHHHHCCC | 5.21 | - | |
310 | Phosphorylation | YLDRNNPSKPLHVIK HHCCCCCCCCEEEEE | 49.37 | 28857561 | |
311 | Ubiquitination | LDRNNPSKPLHVIKG HCCCCCCCCEEEEEC | 53.51 | - | |
317 | Ubiquitination | SKPLHVIKGHSKSIQ CCCEEEEECCCCEEE | 49.86 | - | |
320 | Phosphorylation | LHVIKGHSKSIQCLT EEEEECCCCEEEEEE | 36.45 | 28857561 | |
321 | Acetylation | HVIKGHSKSIQCLTV EEEECCCCEEEEEEE | 46.00 | 23749302 | |
321 | Ubiquitination | HVIKGHSKSIQCLTV EEEECCCCEEEEEEE | 46.00 | - | |
321 | 2-Hydroxyisobutyrylation | HVIKGHSKSIQCLTV EEEECCCCEEEEEEE | 46.00 | - | |
322 | Phosphorylation | VIKGHSKSIQCLTVH EEECCCCEEEEEEEE | 22.39 | 30108239 | |
327 | Phosphorylation | SKSIQCLTVHKNGGK CCEEEEEEEEECCCE | 28.34 | 28857561 | |
327 (in isoform 3) | Ubiquitination | - | 28.34 | 21890473 | |
330 | Acetylation | IQCLTVHKNGGKSYI EEEEEEEECCCEEEE | 53.61 | 25953088 | |
330 | Ubiquitination | IQCLTVHKNGGKSYI EEEEEEEECCCEEEE | 53.61 | - | |
334 | Ubiquitination | TVHKNGGKSYIYSGS EEEECCCEEEEEECC | 41.29 | - | |
334 | Acetylation | TVHKNGGKSYIYSGS EEEECCCEEEEEECC | 41.29 | 26051181 | |
338 | Phosphorylation | NGGKSYIYSGSHDGH CCCEEEEEECCCCCC | 9.95 | 28796482 | |
339 | Phosphorylation | GGKSYIYSGSHDGHI CCEEEEEECCCCCCE | 25.02 | 28857561 | |
340 (in isoform 1) | Acetylation | - | 16.42 | - | |
340 | Acetylation | GKSYIYSGSHDGHIN CEEEEEECCCCCCEE | 16.42 | 19608861 | |
340 | Ubiquitination | GKSYIYSGSHDGHIN CEEEEEECCCCCCEE | 16.42 | 19608861 | |
341 | Phosphorylation | KSYIYSGSHDGHINY EEEEEECCCCCCEEE | 16.68 | 28857561 | |
348 | Phosphorylation | SHDGHINYWDSETGE CCCCCEEEEECCCCC | 15.25 | 28796482 | |
351 | Phosphorylation | GHINYWDSETGENDS CCEEEEECCCCCCCC | 23.94 | 28348404 | |
353 | Phosphorylation | INYWDSETGENDSFA EEEEECCCCCCCCCC | 54.47 | 28348404 | |
358 | Phosphorylation | SETGENDSFAGKGHT CCCCCCCCCCCCCCC | 28.69 | 27251275 | |
362 | Ubiquitination | ENDSFAGKGHTNQVS CCCCCCCCCCCCCEE | 44.05 | 21906983 | |
362 | Acetylation | ENDSFAGKGHTNQVS CCCCCCCCCCCCCEE | 44.05 | 26051181 | |
362 (in isoform 1) | Ubiquitination | - | 44.05 | 21890473 | |
371 (in isoform 1) | Acetylation | - | 3.14 | - | |
371 | Sulfoxidation | HTNQVSRMTVDESGQ CCCCEEEEEECCCCC | 3.14 | 21406390 | |
371 | Acetylation | HTNQVSRMTVDESGQ CCCCEEEEEECCCCC | 3.14 | 19608861 | |
372 | Phosphorylation | TNQVSRMTVDESGQL CCCEEEEEECCCCCE | 24.56 | 21406692 | |
376 | Phosphorylation | SRMTVDESGQLISCS EEEEECCCCCEEEEE | 27.63 | 21406692 | |
381 | Phosphorylation | DESGQLISCSMDDTV CCCCCEEEEECCCHH | 14.56 | 21406692 | |
383 | Phosphorylation | SGQLISCSMDDTVRY CCCEEEEECCCHHEE | 20.60 | 21406692 | |
384 | Sulfoxidation | GQLISCSMDDTVRYT CCEEEEECCCHHEEE | 6.74 | 30846556 | |
387 | Phosphorylation | ISCSMDDTVRYTSLM EEEECCCHHEEEEEE | 11.56 | 21406692 | |
390 | Phosphorylation | SMDDTVRYTSLMLRD ECCCHHEEEEEEEEC | 9.06 | 21406692 | |
391 | Phosphorylation | MDDTVRYTSLMLRDY CCCHHEEEEEEEECC | 12.57 | 21406692 | |
392 | Phosphorylation | DDTVRYTSLMLRDYS CCHHEEEEEEEECCC | 11.66 | 21406692 | |
394 | Sulfoxidation | TVRYTSLMLRDYSGQ HHEEEEEEEECCCCC | 2.63 | 21406390 | |
396 | Methylation | RYTSLMLRDYSGQGV EEEEEEEECCCCCCE | 27.19 | 115919909 | |
398 | Phosphorylation | TSLMLRDYSGQGVVK EEEEEECCCCCCEEE | 14.31 | 23911959 | |
398 | Nitration | TSLMLRDYSGQGVVK EEEEEECCCCCCEEE | 14.31 | - | |
399 | Phosphorylation | SLMLRDYSGQGVVKL EEEEECCCCCCEEEE | 29.00 | 28857561 | |
405 | Ubiquitination | YSGQGVVKLDVQPKC CCCCCEEEEEEECCE | 36.24 | 21890473 | |
405 | Acetylation | YSGQGVVKLDVQPKC CCCCCEEEEEEECCE | 36.24 | 26051181 | |
405 (in isoform 1) | Ubiquitination | - | 36.24 | 21890473 | |
437 | Ubiquitination | VLLKDQRKCFSIDNP EEECCCCCCEECCCC | 33.72 | - | |
440 | Phosphorylation | KDQRKCFSIDNPGYE CCCCCCEECCCCCCC | 38.20 | 28857561 | |
445 (in isoform 3) | Ubiquitination | - | 45.77 | 21890473 | |
446 | Phosphorylation | FSIDNPGYEPEVVAV EECCCCCCCCEEEEE | 29.57 | 28857561 | |
449 (in isoform 3) | Ubiquitination | - | 37.37 | 21890473 | |
472 | Phosphorylation | VDGNVRLYSILGTTL CCCCEEEEEEECCEE | 5.32 | 28796482 | |
473 | Phosphorylation | DGNVRLYSILGTTLK CCCEEEEEEECCEEC | 18.87 | 28796482 | |
477 | Phosphorylation | RLYSILGTTLKDEGK EEEEEECCEECCCCE | 26.05 | 28152594 | |
478 | Phosphorylation | LYSILGTTLKDEGKL EEEEECCEECCCCEE | 29.97 | 28857561 | |
480 | Acetylation | SILGTTLKDEGKLLE EEECCEECCCCEEEE | 52.20 | 19608861 | |
480 | Ubiquitination | SILGTTLKDEGKLLE EEECCEECCCCEEEE | 52.20 | 19608861 | |
480 | Succinylation | SILGTTLKDEGKLLE EEECCEECCCCEEEE | 52.20 | 23954790 | |
480 (in isoform 1) | Ubiquitination | - | 52.20 | 21890473 | |
484 | Ubiquitination | TTLKDEGKLLEAKGP CEECCCCEEEEECCC | 48.10 | 2190698 | |
484 | 2-Hydroxyisobutyrylation | TTLKDEGKLLEAKGP CEECCCCEEEEECCC | 48.10 | - | |
484 (in isoform 1) | Ubiquitination | - | 48.10 | 21890473 | |
489 | Ubiquitination | EGKLLEAKGPVTDVA CCEEEEECCCCCEEE | 55.14 | - | |
489 | 2-Hydroxyisobutyrylation | EGKLLEAKGPVTDVA CCEEEEECCCCCEEE | 55.14 | - | |
507 | S-palmitoylation | DGAFLAVCDASKVVT CCEEEEEECHHCEEE | 2.77 | 29575903 | |
511 | Acetylation | LAVCDASKVVTVFSV EEEECHHCEEEEEEE | 42.31 | 19608861 | |
517 | Phosphorylation | SKVVTVFSVADGYSE HCEEEEEEECCCCCC | 16.44 | 28152594 | |
522 | Phosphorylation | VFSVADGYSENNVFY EEEECCCCCCCCEEE | 17.23 | 28152594 | |
523 | Phosphorylation | FSVADGYSENNVFYG EEECCCCCCCCEEEC | 39.10 | 28152594 | |
529 | Phosphorylation | YSENNVFYGHHAKIV CCCCCEEECCCCEEE | 15.97 | 28152594 | |
557 | Phosphorylation | GGMDMMVYVWTLSDP CCCEEEEEEEECCCH | 3.41 | 26074081 | |
560 | Phosphorylation | DMMVYVWTLSDPETR EEEEEEEECCCHHHE | 13.31 | 26074081 | |
562 | Phosphorylation | MVYVWTLSDPETRVK EEEEEECCCHHHEEE | 43.68 | 26074081 | |
569 | Acetylation | SDPETRVKIQDAHRL CCHHHEEEHHHHHHH | 31.21 | 23749302 | |
569 | Ubiquitination | SDPETRVKIQDAHRL CCHHHEEEHHHHHHH | 31.21 | - | |
569 | 2-Hydroxyisobutyrylation | SDPETRVKIQDAHRL CCHHHEEEHHHHHHH | 31.21 | - | |
580 | Phosphorylation | AHRLHHVSSLAWLDE HHHHHCCCEEEEECC | 18.44 | 28857561 | |
581 | Phosphorylation | HRLHHVSSLAWLDEH HHHHCCCEEEEECCC | 22.48 | 28348404 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of WDR1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of WDR1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of WDR1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-28; LYS-81; LYS-95; LYS-115AND LYS-480, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-238, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-238, AND MASSSPECTROMETRY. |